Lectenz Bio receives a U01 from the NIH Common Fund Glycoscience program to further develop GlycoSenseTM technology. Lectenz Bio receives...
Lectenz Bio News
CSO Lori Yang @ San Diego Startup Week
Dr. Lori Yang, co-Founder and CSO of Lectenz Bio, will be a featured panelist at San Diego Startup Week on June 20th. Dr. Yang will share...
Three mutations switch H7N9 influenza to human-type receptor specificity
Prof. Robert J. Woods, President and co-Founder, and collaborators reported in PLoS Pathogens on Thursday, June 15th that three mutations...
Lectenz Bio receives patent issuance from USPTO
The Lectenz Bio team is excited to announce the approval of its first patent for a carbohydrate-like small molecule inhibitor. This...
CSO Lori Yang talks about her work on International Women’s Day
Lectenz Bio's Chief Scientific Officer and co-founder Lori Yang was recently interviewed by JLabs for her work on International Women's...
Lectenz Bio selected as semi-finalist – Thermo Fisher Scientific Innovation Day
Lectenz Bio team was selected to participate as semi-finalists for the 2016 Thermo Fisher Scientific Innovation Day. This unique program...
CEO Kausar Samli presents at #RESIBOS16 Innovation Challenge
RESI (Redefining Early Stage Investments) seeks to bring together early stage life science companies with strategic investors in order to...
Lectenz Bio earns Best Poster Award at Biomanufacturing Technology Summit
Lectenz Bio received Best Poster recognition at the 2016 Biomanufacturing Technology Summit. The team presented their work on the...
CEO Kausar Samli receives Emerging Leader of the Year Award
Georgia Bio (GaBio) announced Lectenz Bio's CEO, Kausar Samli, as a recipient of the Emerging Leader Award for 2016. The award celebrates...